Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Trabecular bone loss may contribute to axial spondyloarthritis progression

Key clinical point: Trabecular bone loss could predict syndesmophyte formation and disease progression in axial spondyloarthritis.

Major finding: Trabecular bone loss is associated with more syndesmophyte formation than no trabecular bone loss.

Study details: A prospective, observational cohort study in 245 patients with axial spondyloarthritis.

Disclosures: The study received no funding, and the authors said they had no conflicts of interest to declare.


Jung J-Y et al. Semin Arthritis Rheum. 2020;50(5):827-33.